help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rowe, R. C.
Right arrow Articles by Friesen, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowe, R. C.
Right arrow Articles by Friesen, H. G.

Journal of Clinical Endocrinology & Metabolism, Vol 57, 942-946, Copyright © 1983 by Endocrine Society

ARTICLES

Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin

RC Rowe, EA Cowden, C Faiman and HG Friesen

The availability of a sensitive and specific bioassay (BA) for PRL in human serum has made possible a comparative assessment of PRL bioactivity and immunoactivity in normal and abnormal serum specimens. Serum was studied from 20 normal subjects and 54 patients with a variety of disorders relating to PRL secretion. The correlation between the results of both assays was very close in all subjects. The mean BA/RIA ratio in normal subjects was 0.90, with a range from 0.67-1.33, and in patients with disordered PRL secretion the mean BA/RIA ratio was 0.94, with a range from 0.53-1.58. Similar results were obtained with PRL stimulatory testing using TRH, metoclopramide, and domperidone, and samples of culture medium from both PRL-secreting and non-PRL-secreting human pituitary tumor cultures. In one patient with a high proportion of "big, big" PRL and hyperprolactinaemia a BA/RIA ratio of 2.47 was found, a value well outside the normal range. However another patient with a similar history had a ratio of 0.82, in the range observed in normal subjects. These findings indicate that in a wide variety of clinical disorders the correlation between PRL bioactivity in the Nb2 system and immunoactivity in human serum samples is remarkably good under basal and stimulated conditions. One exception was found, but the nature of the underlying PRL abnormality in this patient remains to be investigated.


This article has been cited by other articles:


Home page
 LupusHome page
M Garcia, M E Colombani-Vidal, C C Zylbersztein, A Testi, J Marcos, A Arturi, J Babini, and H E Scaglia
Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus
Lupus, August 1, 2004; 13(8): 575 - 583.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
C. Mounier, J. Trouillas, B. Claustrat, R. Duthel, and B. Estour
Macroprolactinaemia associated with prolactin adenoma
Hum. Reprod., April 1, 2003; 18(4): 853 - 857.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
F Blanco-Favela, K Chavez-Rueda, and A Leanos-Miranda
Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus
Lupus, October 1, 2001; 10(10): 757 - 761.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society